表紙
市場調查報告書
商品編碼
1029951

歐洲針刺活檢市場-到 2028 年的行業趨勢和預測

Europe Needle Biopsy Market - Industry Trends and Forecast to 2028

出版日期: | 出版商: Data Bridge Market Research Private Limited | 英文 160 Pages | 商品交期: 3-5個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

預計歐洲針刺活檢市場從 2021 年到 2028 年將以 6.3% 的複合年增長率增長。

在本報告中,我們調查和分析了歐洲針刺活檢市場,並規範、促進、抑制、市場機遇、挑戰、COVID-19 影響、針頭類型、人體工程學、程序、樣本站點。我們提供了公司信息、公司按類別、實用程序、應用程序、最終用戶、分銷渠道和地區劃分的信息、SWOT 分析和公司簡介。

目錄

第 1 章介紹

第 2 章歐洲針刺活檢市場:細分

  • 目標市場
  • 地理範圍
  • 考慮研究的年份
  • DBMR 三腳架數據驗證模型
  • 主要意見領袖訪談
  • 多元建模
  • 最終用戶生命線圖
  • DBMR 市場頭寸網格
  • 供應商份額分析
  • 市場程序範圍網格
  • 輔助材料
  • 假設

第 3 章執行摘要

第 5 章歐洲針刺活檢市場:法規

第 5.1 章美國法規:

第 5.2 章歐洲法規:

  • 中國法規

第 5 章我國4種醫療器械標籤說明:

  • 日本規則
  • 印度規則

第 6 章市場概覽

  • 促進因素
    • 乳腺癌和肺癌的患病率增加
    • 微創手術需求快速增長
    • 政府倡議提高對肺癌和乳腺癌的認識
    • 穿刺活檢的技術進步
    • 醫療救護針活檢
  • 抑制因素
    • 穿刺活檢的成本增加
    • 磁共振成像等超靈敏成像技術快速發展
    • 與活檢程序相關的感染風險
    • 穿刺活檢的複雜性
  • 市場機會
    • 主要參與者的戰略舉措
    • 增加醫療保健支出和可支配收入
    • 增加研發活動
    • 新興國家市場潛力巨大
  • 挑戰
    • 嚴格的規章制度
    • 主要參與者之間日益激烈的競爭
    • 穿刺活檢的局限性或複雜性

第 7 章歐洲針刺活檢市場:COVID-19 的影響

  • 對價格的影響

第 8 章歐洲針刺活檢市場:按針頭類型

  • 概述
  • TREPHINE BIOPSY NEEDLES
    • 可重複使用
    • 一次性
  • SALAH NEEDLE ASPIRATION NEEDLE
  • KLIMA STERNAL NEEDLE
  • JAMSHIDI NEEDLE
  • 其他

第 9 章歐洲針刺活檢市場:按人體工程學

  • 概述
  • SHARP
  • BLUNT
  • CHIBA
  • FRANSEEN
  • QUINCKE
  • 其他

第 10 章歐洲針刺活檢市場:按程序

  • 概述
  • 細針抽吸活檢
  • 空心針活檢
  • 圖像引導活檢
  • 真空活檢

第 11 章歐洲針刺活檢市場:按樣本站點

  • 概述
  • 骷髏
  • 肌肉
  • 其他器官
    • 胸部
    • 肝臟
    • 其他

第 12 章歐洲針刺活檢市場:按效用

  • 概述
  • 一次性
  • 可重複使用

第 13 章歐洲針刺活檢市場:按應用

  • 概述
  • 腫瘤
    • 肉瘤
    • 爆破造口
    • 生殖細胞腫瘤
    • 其他
  • 感染
  • 炎症
  • 其他

第 14 章歐洲針刺活檢市場:最終用戶

  • 概述
  • 醫院
  • 診斷中心
  • 活檢實驗室
  • 門診手術中心
  • 學術和研究機構
  • 其他

第 15 章歐洲針刺活檢市場:按分銷渠道

  • 概述
  • 直接出價
  • 零售額

第 16 章歐洲針刺活檢市場:按地區

  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 瑞士
    • 比利時
    • 土耳其
    • 其他歐洲

第 17 章歐洲針刺活檢市場:企業現狀

  • 公司份額分析:歐洲

第 18 章SWOT分析

第 19 章公司簡介

  • BOSTON SCIENTIFIC CORPORATION
  • HOLOGIC, INC
  • BD
  • B. BRAUN MELSUNGEN AG
  • COOK
  • AMECATH
  • APRIOMED, AB
  • ARGON MEDICAL
  • CARDINAL HEALTH
  • HAKKO CO., LTD.
  • INRAD, INC.
  • MEDAX SRL
  • MERIT MEDICAL SYSTEMS
  • MOLLER MEDICAL GMBH
  • PAJUNK
  • ST. STONE MEDICAL DEVICES PVT. LTD.
  • SWASTIK ENTERPRISE
  • TSUNAMI MEDICAL SRL
  • WELL GO MEDICAL PRODUCTS GMBH
  • ZAMAR CARE

第 20 章問卷

第 21 章相關報導

目錄

Europe needle biopsy market is projected to register a CAGR of 6.3% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028

Market Segmentation:

Europe Needle Biopsy Market, By Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Procedure (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumor, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centers, Biopsy Labs, Ambulatory Surgical Centers, Academic and Research Organizations, Others), Distribution Channel (Direct Tender, Retail Sales), Country (Germany, France, Italy, U.K., Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, Rest of Europe) Industry Trends and Forecast to 2028

Some of the major factors contributing to the growth of the Europe needle biopsy market are:

  • Rising prevalence of breast and lung cancer
  • Increased demand for minimally invasive surgeries
  • Government initiatives to spread awareness about lung and breast cancer

Market Players:

The key market players for Europe needle biopsy market are listed below:

  • Medax SRL
  • Boston Scientific Corporation
  • Cook
  • Hologic, Inc
  • AprioMed AB
  • Cardinal Health
  • BD
  • Moller Medical GmbH
  • ARGON MEDICAL
  • Leica Biosystems Nussloch GmbH
  • Merit Medical Systems
  • weLLgo Medical Products GmbH
  • Tsunami Medical Srl
  • Pajunk
  • B. Braun Melsungen AG

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF THE EUROPE NEEDLE BIOPSY MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 EUROPE NEEDLE BIOPSY MARKET: SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 END USER LIFELINE CURVE
  • 2.8 DBMR MARKET POSITION GRID
  • 2.9 VENDOR SHARE ANALYSIS
  • 2.10 MARKET PROCEDURE COVERAGE GRID
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

5 EUROPE NEEDLE BIOPSY MARKET: REGULATIONS

5.1 REGULATION IN US:

5.2 REGULATION IN EUROPE:

  • 5.3 REGULATIONS IN CHINA

5.4 MEDICAL DEVICE INSTRUCTIONS FOR LABELLING IN CHINA:

  • 5.5 REGULATIONS IN JAPAN
  • 5.6 REGUALTION IN INDIA

6 MARKET OVERVIEW

  • 6.1 DRIVERS
    • 6.1.1 INCREASED PREVALENCE OF BREAST AND LUNG CANCER
    • 6.1.2 SURGE IN DEMAND FOR MINIMALLY INVASIVE SURGERIES
    • 6.1.3 GOVERNMENT INITIATIVES TO SPREAD AWARENESS ABOUT LUNG AND BREAST CANCER
    • 6.1.4 TECHNOLOGICAL ADVANCEMENT IN NEEDLE BIOPSY
    • 6.1.5 HEALTHCARE REIMBURSEMENT FOR NEEDLE BIOPSY
  • 6.2 RESTRAINTS
    • 6.2.1 RISE IN COST OF THE NEEDLE BIOPSY
    • 6.2.2 RAPID DEVELOPMENT OF ULTRASENSITIVE IMAGING TECHNOLOGIES SUCH AS MAGNETIC RESONANCE IMAGING
    • 6.2.3 RISK OF INFECTION RELATED TO BIOPSY PROCEDURES
    • 6.2.4 COMPLEXITY IN NEEDLE BIOPSY
  • 6.3 OPPORTUNITIES
    • 6.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
    • 6.3.2 RISE IN HEALTHCARE EXPENDITURE AND DISPOSABLE INCOME
    • 1.3.1 INCREASE IN RESEARCH AND DEVELOPMENT ACTIVITIES
    • 6.3.3 HUGE MARKET POTENTIAL IN DEVELOPING COUNTRIES
  • 6.4 CHALLENGES
    • 6.4.1 STRINGENT RULES AND REGULATIONS
    • 6.4.2 RISE IN COMPETITION BETWEEN MARKET PLAYERS
    • 1.4.1 LIMITATIONS OR COMPLICATIONS OF NEEDLE BIOPSY

7 IMPACT OF COVID-19 PANDEMIC ON THE EUROPE NEEDLE BIOPSY MARKET

  • 7.1 PRICE IMPACT

8 EUROPE NEEDLE BIOPSY MARKET, BY NEEDLE TYPE

  • 8.1 OVERVIEW
  • 8.2 TREPHINE BIOPSY NEEDLES
    • 8.2.1 REUSABLE
    • 8.2.2 DISPOSABLE
  • 8.3 SALAH NEEDLE ASPIRATION NEEDLE
  • 8.4 KLIMA STERNAL NEEDLE
  • 8.5 JAMSHIDI NEEDLE
  • 8.6 OTHERS

9 EUROPE NEEDLE BIOPSY MARKET, BY ERGONOMICS

  • 9.1 OVERVIEW
  • 9.2 SHARP
  • 9.3 BLUNT
  • 9.4 CHIBA
  • 9.5 FRANSEEN
  • 9.6 QUINCKE
  • 9.7 OTHERS

10 EUROPE NEEDLE BIOPSY MARKET, BY PROCEDURE

  • 10.1 OVERVIEW
  • 10.2 FINE-NEEDLE ASPIRATION BIOPSY
  • 10.3 CORE NEEDLE BIOPSY
  • 10.4 IMAGE-GUIDED BIOPSY
  • 10.5 VACUUM ASSISTED BIOPSY

11 EUROPE NEEDLE BIOPSY MARKET, BY SAMPLE SITE

  • 11.1 OVERVIEW
  • 11.2 BONES
  • 11.3 MUSCLES
  • 11.4 OTHER ORGANS
    • 11.4.1 BREAST
    • 11.4.2 LIVER
    • 11.4.3 LUNGS
    • 11.4.4 OTHERS

12 EUROPE NEEDLE BIOPSY MARKET, BY UTILITY

  • 12.1 OVERVIEW
  • 12.2 DISPOSABLE
  • 12.3 REUSABLE

13 EUROPE NEEDLE BIOPSY MARKET, BY APPLICATION

  • 13.1 OVERVIEW
  • 13.2 TUMOR
    • 13.2.1 CARCINOMA
    • 13.2.2 SARCOMA
    • 13.2.3 BLASTOMA
    • 13.2.4 GERM CELL TUMOR
    • 13.2.5 OTHERS
  • 13.3 INFECTION
  • 13.4 INFLAMMATION
  • 13.5 OTHERS

14 EUROPE NEEDLE BIOPSY MARKET, BY END USER

  • 14.1 OVERVIEW
  • 14.2 HOSPITALS
  • 14.3 DIAGNOSTIC CENTERS
  • 14.4 BIOPSY LABS
  • 14.5 AMBULATORY SURGICAL CENTERS
  • 14.6 ACADEMIC AND RESEARCH ORGANIZATION
  • 14.7 OTHERS

15 EUROPE NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL

  • 15.1 OVERVIEW
  • 15.2 DIRECT TENDER
  • 15.3 RETAIL SALES

16 EUROPE NEEDLE BIOPSY MARKET, BY REGION

  • 16.1 EUROPE
    • 16.1.1 GERMANY
    • 16.1.2 U.K.
    • 16.1.3 FRANCE
    • 16.1.4 ITALY
    • 16.1.5 SPAIN
    • 16.1.6 NETHERLANDS
    • 16.1.7 RUSSIA
    • 16.1.8 SWITZERLAND
    • 16.1.9 BELGIUM
    • 16.1.10 TURKEY
    • 16.1.11 REST OF EUROPE

17 EUROPE NEEDLE BIOPSY MARKET: COMPANY LANDSCAPE

  • 17.1 COMPANY SHARE ANALYSIS: EUROPE

18 SWOT ANALYSIS

19 COMPANY PROFILE

  • 19.1 BOSTON SCIENTIFIC CORPORATION
    • 19.1.1 COMPANY SNAPSHOT
    • 19.1.2 REVENUE ANALYSIS
    • 19.1.3 COMPANY SHARE ANALYSIS
    • 19.1.4 PRODUCT PORTFOLIO
    • 19.1.5 RECENT DEVELOPMENTS
  • 19.2 HOLOGIC, INC
    • 19.2.1 COMPANY SNAPSHOT
    • 19.2.2 REVENUE ANALYSIS
    • 19.2.3 COMPANY SHARE ANALYSIS
    • 19.2.4 PRODUCT PORTFOLIO
    • 19.2.5 RECENT DEVELOPMENTS
  • 19.3 BD
    • 19.3.1 COMPANY SNAPSHOT
    • 19.3.2 REVENUE ANALYSIS
    • 19.3.3 COMPANY SHARE ANALYSIS
    • 19.3.4 PRODUCT PORTFOLIO
    • 19.3.5 RECENT DEVELOPMENTS
  • 19.4 B. BRAUN MELSUNGEN AG
    • 19.4.1 COMPANY SNAPSHOT
    • 19.4.2 REVENUE ANALYSIS
    • 19.4.3 COMPANY SHARE ANALYSIS
    • 19.4.4 PRODUCT PORTFOLIO
    • 19.4.5 RECENT DEVELOPMENTS
  • 19.5 COOK
    • 19.5.1 COMPANY SNAPSHOT
    • 19.5.2 COMPANY SHARE ANALYSIS
    • 19.5.3 PRODUCT PORTFOLIO
    • 19.5.4 RECENT DEVELOPMENTS
  • 19.6 AMECATH
    • 19.6.1 COMPANY SNAPSHOT
    • 19.6.2 PRODUCT PORTFOLIO
    • 19.6.3 RECENT DEVELOPMENTS
  • 19.7 APRIOMED, AB
    • 19.7.1 COMPANY SNAPSHOT
    • 19.7.2 PRODUCT PORTFOLIO
    • 19.7.3 RECENT DEVELOPMENT
  • 19.8 ARGON MEDICAL
    • 19.8.1 COMPANY SNAPSHOT
    • 19.8.2 PRODUCT PORTFOLIO
    • 19.8.3 RECENT DEVELOPMENT
  • 19.9 CARDINAL HEALTH
    • 19.9.1 COMPANY SNAPSHOT
    • 19.9.2 REVENUE ANALYSIS
    • 19.9.3 PRODUCT PORTFOLIO
    • 19.9.4 RECENT DEVELOPMENT
  • 19.10 HAKKO CO., LTD.
    • 19.10.1 COMPANY SNAPSHOT
    • 19.10.2 PRODUCT PORTFOLIO
    • 19.10.3 RECENT DEVELOPMENT
  • 19.11 INRAD, INC.
    • 19.11.1 COMPANY SNAPSHOT
    • 19.11.2 PRODUCT PORTFOLIO
    • 19.11.3 RECENT DEVELOPMENT
  • 19.12 MEDAX SRL
    • 19.12.1 COMPANY SNAPSHOT
    • 19.12.2 PRODUCT PORTFOLIO
    • 19.12.3 RECENT DEVELOPMENT
  • 19.13 MERIT MEDICAL SYSTEMS
    • 19.13.1 COMPANY SNAPSHOT
    • 19.13.2 REVENUE ANALYSIS
    • 19.13.3 PRODUCT PORTFOLIO
    • 19.13.4 RECENT DEVELOPMENTS
  • 19.14 MOLLER MEDICAL GMBH
    • 19.14.1 COMPANY SNAPSHOT
    • 19.14.2 PRODUCT PORTFOLIO
    • 19.14.3 RECENT DEVELOPMENTS
  • 19.15 PAJUNK
    • 19.15.1 COMPANY SNAPSHOT
    • 19.15.2 PRODUCT PORTFOLIO
    • 19.15.3 RECENT DEVELOPMENT
  • 19.16 ST. STONE MEDICAL DEVICES PVT. LTD.
    • 19.16.1 COMPANY SNAPSHOT
    • 19.16.2 PRODUCT PORTFOLIO
    • 19.16.3 RECENT DEVELOPMENT
  • 19.17 SWASTIK ENTERPRISE
    • 19.17.1 COMPANY SNAPSHOT
    • 19.17.2 PRODUCT PORTFOLIO
    • 19.17.3 RECENT DEVELOPMENT
  • 19.18 TSUNAMI MEDICAL SRL
    • 19.18.1 COMPANY SNAPSHOT
    • 19.18.2 PRODUCT PORTFOLIO
    • 19.18.3 RECENT DEVELOPMENTS
  • 19.19 WELL GO MEDICAL PRODUCTS GMBH
    • 19.19.1 COMPANY SNAPSHOT
    • 19.19.2 PRODUCT PORTFOLIO
    • 19.19.3 RECENT DEVELOPMENT
  • 19.20 ZAMAR CARE
    • 19.20.1 COMPANY SNAPSHOT
    • 19.20.2 PRODUCT PORTFOLIO
    • 19.20.3 RECENT DEVELOPMENT

20 QUESTIONNAIRE

21 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 EUROPE NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 2 EUROPE TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 3 EUROPE TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 4 EUROPE SALAH NEEDLE ASPIRATION NEEDLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 5 EUROPE KLIMA STERNAL NEEDLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 6 EUROPE JAMSHIDI NEEDLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 7 EUROPE OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 8 EUROPE NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 9 EUROPE SHARP IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 10 EUROPE BLUNT IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 11 EUROPE CHIBA IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 12 EUROPE FRANSEEN IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 13 EUROPE QUINCKE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 14 EUROPE OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 15 EUROPE NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 16 EUROPE FINE NEEDLE ASPIRATION BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 17 EUROPE CORE NEEDLE BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 18 EUROPE IMAGE GUIDED BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 19 EUROPE VACUUM ASSITED BIOPSY IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 20 EUROPE NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 21 EUROPE BONES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 22 EUROPE MUSCLES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 23 EUROPE OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION
  • TABLE 24 EUROPE OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 25 EUROPE NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 26 EUROPE DISPOSABLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 27 EUROPE REUSABLE IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 28 EUROPE NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 29 EUROPE TUMOR IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 30 EUROPE TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 31 EUROPE INFECTION IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 32 EUROPE INFLAMMATION IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 33 EUROPE OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 34 EUROPE NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 35 EUROPE HOSPITALS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 36 EUROPE DIAGNOSTIC CENTERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 37 EUROPE BIOPSY LABS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 38 EUROPE AMBULATORY SURGICAL CENTERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 39 EUROPE ACADEMIC AND RESEARCH ORGANIZATION IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 40 EUROPE OTHERS IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 41 EUROPE NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 42 EUROPE DIRECT TENDER IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 43 EUROPE RETAIL SALES IN NEEDLE BIOPSY MARKET, BY REGION, 2019-2028 (USD MILLION)
  • TABLE 44 EUROPE NEEDLE BIOPSY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
  • TABLE 45 EUROPE NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 46 EUROPE TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 47 EUROPE NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 48 EUROPE NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 49 EUROPE NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 50 EUROPE OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 51 EUROPE NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 52 EUROPE NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 53 EUROPE TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 54 EUROPE NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 55 EUROPE NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 56 GERMANY NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 57 GERMANY TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 58 GERMANY NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 59 GERMANY NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 60 GERMANY NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 61 GERMANY OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 62 GERMANY NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 63 GERMANY NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 64 GERMANY TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 65 GERMANY NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 66 GERMANY NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 67 U.K. NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 68 U.K. TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 69 U.K. NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 70 U.K. NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 71 U.K. NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 72 U.K. OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 73 U.K. NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 74 U.K. NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 75 U.K. TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 76 U.K. NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 77 U.K. NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 78 FRANCE NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 79 FRANCE TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 80 FRANCE NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 81 FRANCE NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 82 FRANCE NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 83 FRANCE OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 84 FRANCE NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 85 FRANCE NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 86 FRANCE TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 87 FRANCE NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 88 FRANCE NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 89 ITALY NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 90 ITALY TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 91 ITALY NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 92 ITALY NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 93 ITALY NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 94 ITALY OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 95 ITALY NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 96 ITALY NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 97 ITALY TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 98 ITALY NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 99 ITALY NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 100 SPAIN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 101 SPAIN TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 102 SPAIN NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 103 SPAIN NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 104 SPAIN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 105 SPAIN OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 106 SPAIN NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 107 SPAIN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 108 SPAIN TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 109 SPAIN NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 110 SPAIN NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 111 NETHERLANDS NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 112 NETHERLANDS TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 113 NETHERLANDS NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 114 NETHERLANDS NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 115 NETHERLANDS NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 116 NETHERLANDS OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 117 NETHERLANDS NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 118 NETHERLANDS NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 119 NETHERLANDS TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 120 NETHERLANDS NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 121 NETHERLANDS NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 122 RUSSIA NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 123 RUSSIA TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 124 RUSSIA NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 125 RUSSIA NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 126 RUSSIA NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 127 RUSSIA OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 128 RUSSIA NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 129 RUSSIA NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 130 RUSSIA TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 131 RUSSIA NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 132 RUSSIA NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 133 SWITZERLAND NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 134 SWITZERLAND TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 135 SWITZERLAND NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 136 SWITZERLAND NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 137 SWITZERLAND NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 138 SWITZERLAND OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 139 SWITZERLAND NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 140 SWITZERLAND NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 141 SWITZERLAND TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 142 SWITZERLAND NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 143 SWITZERLAND NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 144 BELGIUM NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 145 BELGIUM TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 146 BELGIUM NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 147 BELGIUM NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 148 BELGIUM NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 149 BELGIUM OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 150 BELGIUM NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 151 BELGIUM NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 152 BELGIUM TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 153 BELGIUM NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 154 BELGIUM NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 155 TURKEY NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 156 TURKEY TREPHINE BIOPSY NEEDLES IN NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)
  • TABLE 157 TURKEY NEEDLE BIOPSY MARKET, BY ERGONOMICS, 2019-2028 (USD MILLION)
  • TABLE 158 TURKEY NEEDLE BIOPSY MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)
  • TABLE 159 TURKEY NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 160 TURKEY OTHER ORGANS IN NEEDLE BIOPSY MARKET, BY SAMPLE SITE, 2019-2028 (USD MILLION)
  • TABLE 161 TURKEY NEEDLE BIOPSY MARKET, BY UTILITY, 2019-2028 (USD MILLION)
  • TABLE 162 TURKEY NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 163 TURKEY TUMOR IN NEEDLE BIOPSY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
  • TABLE 164 TURKEY NEEDLE BIOPSY MARKET, BY END USER, 2019-2028 (USD MILLION)
  • TABLE 165 TURKEY NEEDLE BIOPSY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
  • TABLE 166 REST OF EUROPE NEEDLE BIOPSY MARKET, BY NEEDLE TYPE, 2019-2028 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE NEEDLE BIOPSY MARKET: SEGMENTATION
  • FIGURE 2 EUROPE NEEDLE BIOPSY MARKET: DATA TRIANGULATION
  • FIGURE 3 EUROPE NEEDLE BIOPSY MARKET: DROC ANALYSIS
  • FIGURE 4 EUROPE NEEDLE BIOPSY MARKET: EUROPE VS REGIONAL ANALYSIS
  • FIGURE 5 EUROPE NEEDLE BIOPSY MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 EUROPE NEEDLE BIOPSY MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 EUROPE NEEDLE BIOPSY MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 EUROPE NEEDLE BIOPSY MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 9 EUROPE NEEDLE BIOPSY MARKET: MARKET PROCEDURE OVERAGE GRID
  • FIGURE 10 EUROPE NEEDLE BIOPSY MARKET: SEGMENTATION
  • FIGURE 11 RISING PREVALENCE OF BREAST AND LUNG CANCER, AND INCREASE IN DEMAND OF MINIMALLY INVASIVE SURGERIES AND PRESENCE OF HEALTHCARE REIMBURSEMENT IS EXPECTED TO DRIVE THE EUROPE NEEDLE BIOPSY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
  • FIGURE 12 REAGENTS & KITS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE NEEDLE BIOPSY MARKET IN 2021 & 2028
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPRTUNITIES AND CHALLENGES OF EUROPE NEEDLE BIOPSY MARKET
  • FIGURE 14 PREVALENCE OF BREAST CANCER IN EUROPE, INDIA AND IN THE U.S.
  • FIGURE 15 PREVALENCE OF LUNG CANCER IN VARIOUS COUNTRIES, WITH HUNGARY BEING THE HIGHEST PREVALENCE RATE IN WOMEN AND MEN
  • FIGURE 16 EUROPE NEEDLE BIOPSY MARKET: BY NEEDLE TYPE, 2020
  • FIGURE 17 EUROPE NEEDLE BIOPSY MARKET: BY NEEDLE TYPE, 2021-2028 (USD MILLION)
  • FIGURE 18 EUROPE NEEDLE BIOPSY MARKET: BY NEEDLE TYPE, CAGR (2021-2028)
  • FIGURE 19 EUROPE NEEDLE BIOPSY MARKET: BY NEEDLE TYPE, LIFELINE CURVE
  • FIGURE 20 EUROPE NEEDLE BIOPSY MARKET: BY ERGONOMICS, 2020
  • FIGURE 21 EUROPE NEEDLE BIOPSY MARKET: BY ERGONOMICS, 2021-2028 (USD MILLION)
  • FIGURE 22 EUROPE NEEDLE BIOPSY MARKET: BY ERGONOMICS, CAGR (2021-2028)
  • FIGURE 23 EUROPE NEEDLE BIOPSY MARKET: BY ERGONOMICS, LIFELINE CURVE
  • FIGURE 24 EUROPE NEEDLE BIOPSY MARKET: BY PROCEDURE, 2020
  • FIGURE 25 EUROPE NEEDLE BIOPSY MARKET: BY PROCEDURE, 2021-2028 (USD MILLION)
  • FIGURE 26 EUROPE NEEDLE BIOPSY MARKET: BY PROCEDURE, CAGR (2021-2028)
  • FIGURE 27 EUROPE NEEDLE BIOPSY MARKET: BY PROCEDURE, LIFELINE CURVE
  • FIGURE 28 EUROPE NEEDLE BIOPSY MARKET: BY SAMPLE SITE, 2020
  • FIGURE 29 EUROPE NEEDLE BIOPSY MARKET: BY SAMPLE SITE, 2021-2028 (USD MILLION)
  • FIGURE 30 EUROPE NEEDLE BIOPSY MARKET: BY SAMPLE SITE, CAGR (2021-2028)
  • FIGURE 31 EUROPE NEEDLE BIOPSY MARKET: BY SAMPLE SITE, LIFELINE CURVE
  • FIGURE 32 EUROPE NEEDLE BIOPSY MARKET: BY UTILITY, 2020
  • FIGURE 33 EUROPE NEEDLE BIOPSY MARKET: BY UTILITY, 2021-2028 (USD MILLION)
  • FIGURE 34 EUROPE NEEDLE BIOPSY MARKET: BY UTILITY, CAGR (2021-2028)
  • FIGURE 35 EUROPE NEEDLE BIOPSY MARKET: BY UTILITY, LIFELINE CURVE
  • FIGURE 36 EUROPE NEEDLE BIOPSY MARKET: BY APPLICATION, 2020
  • FIGURE 37 EUROPE NEEDLE BIOPSY MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
  • FIGURE 38 EUROPE NEEDLE BIOPSY MARKET: BY APPLICATION, CAGR (2021-2028)
  • FIGURE 39 EUROPE NEEDLE BIOPSY MARKET: BY APPLICATION, LIFELINE CURVE
  • FIGURE 40 EUROPE NEEDLE BIOPSY MARKET: BY END USER, 2020
  • FIGURE 41 EUROPE NEEDLE BIOPSY MARKET: BY END USER, 2021-2028 (USD MILLION)
  • FIGURE 42 EUROPE NEEDLE BIOPSY MARKET: BY END USER, CAGR (2021-2028)
  • FIGURE 43 EUROPE NEEDLE BIOPSY MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 44 EUROPE NEEDLE BIOPSY MARKET: BY DISTRIBUTION CHANNEL, 2020
  • FIGURE 45 EUROPE NEEDLE BIOPSY MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
  • FIGURE 46 EUROPE NEEDLE BIOPSY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
  • FIGURE 47 EUROPE NEEDLE BIOPSY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 48 EUROPE NEEDLE BIOPSY MARKET: SNAPSHOT (2020)
  • FIGURE 49 EUROPE NEEDLE BIOPSY MARKET: BY COUNTRY (2020)
  • FIGURE 50 EUROPE NEEDLE BIOPSY MARKET: BY COUNTRY (2021 & 2028)
  • FIGURE 51 EUROPE NEEDLE BIOPSY MARKET: BY COUNTRY (2020 & 2028)
  • FIGURE 52 EUROPE NEEDLE BIOPSY MARKET: BY NEEDLE TYPE (2021-2028)
  • FIGURE 53 EUROPE NEEDLE BIOPSY MARKET: COMPANY SHARE 2020 (%)